Skip to content

Effect of Age on PRF Quality; Assessed by Evaluating Healing Outcomes of ARP

Effect of Age on PRF Quality; Assessed by Evaluating Healing Outcomes of ARP

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07023757
Enrollment
44
Registered
2025-06-17
Start date
2025-06-12
Completion date
2027-07-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healing Wound

Brief summary

This study will examine whether using PRF and your age are going to affect the healing and regeneration benefits gained from PRF.

Detailed description

Platelet-rich fibrin (PRF) is commonly used to enhance gum tissue healing and reducing pain after tooth extraction and before placing a dental implant. 44 patients requiring a tooth extraction will be recruited and randomized to receive a collagen plug with or without platelet-rich fibrin.

Interventions

PROCEDURESocket preservation

After tooth extraction, the extraction socket will be filled with a collagen plug in one group or a platelet-rich fibrin plug in the other.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age range: 20 to 80 years. 2. Patients must require tooth extraction (molars) as a result of caries, periodontal disease, tooth fracture or deemed unrestorable. 3. Non-infected sockets with intact buccal bone (≥1.5 mm in thickness measured through calipers) 4. Patients interested in implant placement following tooth extraction.

Exclusion criteria

1. Allergies or hypersensitivities to study related medications. 2. Hematologic disorders/blood dyscrasias. 3. Active infectious diseases of any kind. 4. Liver or kidney dysfunction/failure. 5. Uncontrolled diabetes (HbA1c \> 8). 6. Active cancer treatment - such as active chemotherapy or radiation therapy. 7. Taking medications that will affect their bone healing (for example, bisphosphonates, Long-term NSAIDs use, Steroid). 8. Metabolic bone diseases that affect bone healing such as osteoporosis. 9. Pregnant or lactating women (self-reported). 10. Smoke 10 or more cigarettes per day (self-reported). 11. Poor oral hygiene. 12. Systemic diseases that compromise the immune system 13. Anti-coagulant therapy

Design outcomes

Primary

MeasureTime frameDescription
Alveolar ridge dimension changes4 monthsDigitally measured alveolar ridge dimension changes in mm\^2 using cone-beam computed tomography
Soft tissue dimension changes4 monthsDigitally measured soft tissue changes in mm\^2 using intraoral scans

Secondary

MeasureTime frameDescription
Histological bone density.4 monthsHistomorphometry.
Presence of bone turnover proteins.4 monthsImmunohistochemistry.
Amount of growth factorsAt baseline surgeryGrowth factors (PDGF, VEGF and TGF b1) from PRF obtained from drawn blood
Wound healing index1 week, 2 weeks, 4 weeks, and 8 weeksWound healing index (WHI) according to the following scheme: Score "1" for uneventful wound healing with no gingival edema, erythema, suppuration, discomfort or barrier exposure; Score "2" for uneventful wound healing with slight gingival edema, erythema, or discomfort but no suppuration; Score "3" for poor wound healing with significant gingival edema, erythema, discomfort, loss of barrier or any suppuration.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMuhammad Saleh, BDS, MSD

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026